Structural properties of matrix metalloproteinases

被引:309
作者
Bode, W [1 ]
Fernandez-Catalan, C
Tschesche, H
Grams, F
Nagase, H
Maskos, K
机构
[1] Max Planck Inst Biochem, D-82152 Martinsried, Germany
[2] Univ Bielefeld, Abt Biochem 1, D-33615 Bielefeld, Germany
[3] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA
关键词
matrix metalloproteinases (MMPs); tissue inhibitors of metalloproteinases (TIMPs); crystal structures; proteinases; drug design;
D O I
10.1007/s000180050320
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Matrix metalloproteinases (MMPs) are involved in extracellular matrix degradation. Their proteolytic activity must. be precisely regulated by their endogenous protein inhibitors, the tissue inhibitors of metalloproteinases (TIMPs). Disruption of this balance results in serious diseases such as arthritis, tumour growth and metastasis. Knowledge of the tertiary structures of the proteins involved is crucial for understanding their functional properties and interference with associated dysfunctions. Within the last few years, several three-dimensional MMP and MMP-TIMP structures became available, showing the domain organization, polypeptide fold and main specificity determinants. Complexes of the catalytic MMP domains with various synthetic inhibitors enabled the structure-based design and improvement of high-affinity ligands, which might be elaborated into drugs. A multitude of reviews surveying work done on all aspects of MMPs have appeared in recent years, but none of them has focused on the three-dimensional structures. This review was written to close the gap.
引用
收藏
页码:639 / 652
页数:14
相关论文
共 89 条
  • [21] SETOR - HARDWARE-LIGHTED 3-DIMENSIONAL SOLID MODEL REPRESENTATIONS OF MACROMOLECULES
    EVANS, SV
    [J]. JOURNAL OF MOLECULAR GRAPHICS, 1993, 11 (02): : 134 - &
  • [22] 1.8-ANGSTROM CRYSTAL-STRUCTURE OF THE C-TERMINAL DOMAIN OF RABBIT SERUM HEMOPEXIN
    FABER, HR
    GROOM, CR
    BAKER, HM
    MORGAN, WT
    SMITH, A
    BAKER, EN
    [J]. STRUCTURE, 1995, 3 (06) : 551 - 559
  • [23] Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor
    Fernandez-Catalan, C
    Bode, W
    Huber, R
    Turk, D
    Calvete, JJ
    Lichte, A
    Tschesche, H
    Maskos, K
    [J]. EMBO JOURNAL, 1998, 17 (17) : 5238 - 5248
  • [24] The C-terminal (haemopexin-like) domain structure of human gelatinase A (MMP2): Structural implications for its function
    Gohlke, U
    GomisRuth, FX
    Crabbe, T
    Murphy, G
    Docherty, AJP
    Bode, W
    [J]. FEBS LETTERS, 1996, 378 (02) : 126 - 130
  • [25] GOLDBERG GI, 1986, J BIOL CHEM, V261, P6600
  • [26] Gomez DE, 1997, EUR J CELL BIOL, V74, P111
  • [27] The helping hand of collagenase-3 (MMP-13): 2.7 angstrom crystal structure of its C-terminal haemopexin-like domain
    GomisRuth, FX
    Gohlke, U
    Betz, M
    Knauper, V
    Murphy, G
    LopezOtin, C
    Bode, W
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1996, 264 (03) : 556 - 566
  • [28] Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1
    GomisRuth, FX
    Maskos, K
    Betz, M
    Bergner, A
    Huber, R
    Suzuki, K
    Yoshida, N
    Nagase, H
    Brew, K
    Bourenkov, GP
    Bartunik, H
    Bode, W
    [J]. NATURE, 1997, 389 (6646) : 77 - 81
  • [29] THE NMR STRUCTURE OF THE INHIBITED CATALYTIC DOMAIN OF HUMAN STROMELYSIN-1
    GOOLEY, PR
    OCONNELL, JF
    MARCY, AI
    CUCA, GC
    SALOWE, SP
    BUSH, BL
    HERMES, JD
    ESSER, CK
    HAGMANN, WK
    SPRINGER, JP
    JOHNSON, BA
    [J]. NATURE STRUCTURAL BIOLOGY, 1994, 1 (02): : 111 - 118
  • [30] Structure of astacin with a transition-state analogue inhibitor
    Grams, F
    Dive, V
    Yiotakis, A
    Yiallouros, I
    Vassiliou, S
    Zwilling, R
    Bode, W
    Stocker, W
    [J]. NATURE STRUCTURAL BIOLOGY, 1996, 3 (08): : 671 - 675